{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:19:23Z","timestamp":1793366363384,"version":"4.5.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Developing novel therapeutic approaches to defeat chemoresistance is the major goal of ovarian cancer research. Induction of ferroptosis has shown promising antitumor effects in ovarian cancer cells, but the existence of still undefined genetic and metabolic determinants of susceptibility has so far limited the application of ferroptosis inducers <jats:italic>in vivo<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Erastin and\/or the iron compound ferlixit were used to trigger ferroptosis in HEY, COV318, PEO4, and A2780CP ovarian cancer cell lines. Cell viability and cell death were measured by MTT and PI flow cytometry assay, respectively. The \u201cballooning\u201d phenotype was tested as ferroptosis specific morphological feature. Mitochondrial dysfunction was evaluated based on ultrastructural changes, mitochondrial ROS, and mitochondrial membrane polarization. Lipid peroxidation was tested through both C11-BODIPY and malondialdehyde assays. VDAC2 and GPX4 protein levels were quantified as additional putative indicators of mitochondrial dysfunction or lipid peroxidation, respectively. The effect of erastin\/ferlixit treatments on iron metabolism was analyzed by measuring intracellular labile iron pool and ROS. FtH and NCOA4 were measured as biomarkers of ferritinophagy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Here, we provide evidence that erastin is unable to induce ferroptosis in a series of ovarian cancer cell lines. In HEY cells, provided with a high intracellular labile iron pool, erastin treatment is accompanied by NCOA4-mediated ferritinophagy and mitochondrial dysfunction, thus triggering ferroptosis. In agreement, iron chelation counteracts erastin-induced ferroptosis in these cells. COV318 cells, with low baseline intracellular labile iron pool, appear resistant to erastin treatment. Notably, the use of ferlixit sensitizes COV318 cells to erastin through a NCOA4-independent intracellular iron accumulation and mitochondrial dysfunction. Ferlixit alone mimics erastin effects and promotes ferroptosis in HEY cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study proposes both the baseline and the induced intracellular free iron level as a significant determinant of ferroptosis sensitivity and discusses the potential use of ferlixit in combination with erastin to overcome ferroptosis chemoresistance in ovarian cancer.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.868351","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:09:59Z","timestamp":1648724999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":64,"title":["Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells"],"prefix":"10.3389","volume":"12","author":[{"given":"Anna Martina","family":"Battaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Daniela","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Faniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Torella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Biamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/S13048-019-0484-6","article-title":"Current Strategies for the Targeted Treatment of High-Grade Serous Epithelial Ovarian Cancer and Relevance of BRCA Mutational Status","volume":"12","author":"Gadducci","year":"2019","journal-title":"J Ovarian Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2020.564601","article-title":"PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance","volume":"8","author":"Rose","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-42221-x","article-title":"MicroRNA Let-7g Acts as Tumor Suppressor and Predictive Biomarker for Chemoresistance in Human Epithelial Ovarian Cancer","volume":"9","author":"Biamonte","year":"2019","journal-title":"Sci Rep 2019 91"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/CELLS9061505","article-title":"Ferroptosis and Cancer: Mitochondria Meet the \u201cIron Maiden\u201d Cell Death","volume":"9","author":"Battaglia","year":"2020","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.18632\/ONCOTARGET.27749","article-title":"Ferroptosis of Epithelial Ovarian Cancer: Genetic Determinants and Therapeutic Potential","volume":"11","author":"Lin","year":"2020","journal-title":"Oncotarget"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2019.01398","article-title":"Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/MC.22474","article-title":"Contribution of Reactive Oxygen Species to Ovarian Cancer Cell Growth Arrest and Killing by the Anti-Malarial Drug Artesunate","volume":"56","author":"Greenshields","year":"2017","journal-title":"Mol Carcinog"},{"key":"B8","doi-asserted-by":"publisher","first-page":"101928","DOI":"10.1016\/J.REDOX.2021.101928","article-title":"PARP Inhibition Promotes Ferroptosis via Repressing SLC7A11 and Synergizes With Ferroptosis Inducers in BRCA-Proficient Ovarian Cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/J.GENDIS.2020.09.005","article-title":"Ferroptosis: An Emerging Therapeutic Opportunity for Cancer","volume":"9","author":"Wang","year":"2020","journal-title":"Genes Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/S13045-019-0720-Y","article-title":"Ferroptosis, a New Form of Cell Death: Opportunities and Challenges in Cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2019.00139","article-title":"Mechanisms of Ferroptosis and Relations With Regulated Cell Death: A Review","volume":"10","author":"Lei","year":"2019","journal-title":"Front Physiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2019.00238","article-title":"NCOA4-Mediated Ferritinophagy: A Potential Link to Neurodegeneration","volume":"13","author":"Del Rey","year":"2019","journal-title":"Front Neurosci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/HEP.28251","article-title":"Activation of the P62-Keap1-NRF2 Pathway Protects Against Ferroptosis in Hepatocellular Carcinoma Cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/S41418-019-0393-7","article-title":"Kinome Screen of Ferroptosis Reveals a Novel Role of ATM in Regulating Iron Metabolism","volume":"27","author":"Chen","year":"2020","journal-title":"Cell Death Differ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ONC.2017.11","article-title":"Iron Addiction: A Novel Therapeutic Target in Ovarian Cancer","volume":"36","author":"Basuli","year":"2017","journal-title":"Oncogene"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2020.01061","article-title":"The Mechanism of Ferroptosis and Applications in Tumor Treatment","volume":"11","author":"Lin","year":"2020","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12935-021-02366-0\/FIGURES\/5","article-title":"Induction and Application of Ferroptosis in Cancer Therapy","volume":"22","author":"Nie","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/OR.2019.7189","article-title":"Sulfasalazine\u2212induced Ferroptosis in Breast Cancer Cells Is Reduced by the Inhibitory Effect of Estrogen Receptor on the Transferrin Receptor","volume":"42","author":"Yu","year":"2019","journal-title":"Oncol Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/J.CANLET.2018.06.018","article-title":"CISD2 Inhibition Overcomes Resistance to Sulfasalazine-Induced Ferroptotic Cell Death in Head and Neck Cancer","volume":"432","author":"Kim","year":"2018","journal-title":"Cancer Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2021.765859\/BIBTEX","article-title":"Ferroptosis: The Silver Lining of Cancer Therapy","volume":"9","author":"Tang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.665945","article-title":"Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0247-8_11","article-title":"Detection of Ferroptosis by BODIPY\u2122 581\/591 C11","volume":"2108","author":"Martinez","year":"2020","journal-title":"Methods Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1216-3","article-title":"Ferritin Heavy Subunit Enhances Apoptosis of Non-Small Cell Lung Cancer Cells Through Modulation of miR-125b\/P53 Axis","volume":"9","author":"Biamonte","year":"2018","journal-title":"Cell Death Dis 2018 912"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2020.00698\/FULL","article-title":"FtH-Mediated ROS Dysregulation Promotes CXCL12\/CXCR4 Axis Activation and EMT-Like Trans-Differentiation in Erythroleukemia K562 Cells","volume":"10","author":"Chirillo","year":"2020","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.14715\/CMB\/2017.63.11.14","article-title":"Human Haematological and Epithelial Tumor-Derived Cell Lines Express Distinct Patterns of Onco-microRNAs","volume":"63","author":"Biamonte","year":"2017","journal-title":"Cell Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/ODI.13525","article-title":"Gene Expression Analysis of Autofluorescence Margins in Leukoplakia and Oral Carcinoma: A Pilot Study","volume":"27","author":"Biamonte","year":"2021","journal-title":"Oral Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: Past, Present and Future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis 2020 112"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04490-1","article-title":"Double-Edge Sword Roles of Iron in Driving Energy Production Versus Instigating Ferroptosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis 2021 131"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2020.590226","article-title":"Iron Metabolism in Ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3390\/CELLS10092431\/S1","article-title":"Uncovering the Metabolic and Stress Responses of Human Embryonic Stem Cells to FTH1 Gene Silencing","volume":"10","author":"Scaramuzzino","year":"2021","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CELLS10020303","article-title":"Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response","volume":"10","author":"Sacco","year":"2021","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/J.FREERADBIOMED.2015.07.161","article-title":"H Ferritin Silencing Induces Protein Misfolding in K562 Cells: A Raman Analysis","volume":"89","author":"Zolea","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0122105","article-title":"H-Ferritin-Regulated MicroRNAs Modulate Gene Expression in K562 Cells","volume":"10","author":"Biamonte","year":"2015","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.2147\/OTT.S254995","article-title":"The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-14324-x","article-title":"Nedd4 Ubiquitylates VDAC2\/3 to Suppress Erastin-Induced Ferroptosis in Melanoma","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun 2020 111"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/CANCERS11121887","article-title":"Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease","volume":"11","author":"Nath","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/S12885-016-2999-1","article-title":"Molecular Chess? Hallmarks of Anti-Cancer Drug Resistance","volume":"17","author":"Cree","year":"2017","journal-title":"BMC Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/JCMM.13008","article-title":"Ferroptosis, a New Form of Cell Death, and Its Relationships With Tumourous Diseases","volume":"21","author":"Yu","year":"2017","journal-title":"J Cell Mol Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/JBC.M112.433847","article-title":"Voltage-Dependent Anion Channels Modulate Mitochondrial Metabolism in Cancer Cells: Regulation by Free Tubulin and Erastin","volume":"288","author":"Maldonado","year":"2013","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJCB.2019.151058","article-title":"Mitochondria Regulation in Ferroptosis","volume":"220","author":"Wang","year":"2020","journal-title":"Eur J Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/J.MOLCEL.2018.10.042","article-title":"Role of Mitochondria in Ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2020.00476","article-title":"Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology","volume":"10","author":"Brown","year":"2020","journal-title":"Front Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCELL.2019.04.002","article-title":"Targeting Ferroptosis to Iron Out Cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.3390\/CELLS10112981","article-title":"Ferroptosis: Cancer Stem Cells Rely on Iron Until \u201cTo Die for\u201d It","volume":"10","author":"Cosialls","year":"2021","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/S00432-018-2699-0","article-title":"Cell Growth Potential Drives Ferroptosis Susceptibility in Rhabdomyosarcoma and Myoblast Cell Lines","volume":"144","author":"Codenotti","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3461251","DOI":"10.1155\/2019\/3461251","article-title":"H-Ferritin Affects Cisplatin-Induced Cytotoxicity in Ovarian Cancer Cells Through the Modulation of ROS","volume":"2019","author":"Salatino","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/IJMS18102167","article-title":"Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 Up-Regulation and GATA-1 Repression","volume":"18","author":"Zolea","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0163078","article-title":"Caffeine Positively Modulates Ferritin Heavy Chain Expression in H460 Cells: Effects on Cell Proliferation","volume":"11","author":"Zolea","year":"2016","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0151359","article-title":"FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated During Cell Differentiation","volume":"11","author":"Di Sanzo","year":"2016","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/J.GENE.2018.03.027","article-title":"shRNA Targeting of Ferritin Heavy Chain Activates H19\/miR-675 Axis in K562 Cells","volume":"657","author":"Di Sanzo","year":"2018","journal-title":"Gene"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2010.02.005","article-title":"Cytosolic and Mitochondrial Ferritins in the Regulation of Cellular Iron Homeostasis and Oxidative Damage","volume":"1800","author":"Arosio","year":"2010","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"B53","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/ACSCENTSCI.0C01592\/SUPPL_FILE\/OC0C01592_SI_001.PDF","article-title":"Inhibiting Ferroptosis Through Disrupting the NCOA4-FTH1 Interaction: A New Mechanism of Action","volume":"7","author":"Fang","year":"2021","journal-title":"ACS Cent Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3892\/OL.2019.11159","article-title":"Potential Mechanism of Ferroptosis in Pancreatic Cancer","volume":"19","author":"Chen","year":"2020","journal-title":"Oncol Lett"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399407000531","article-title":"Iron-Regulatory Proteins: Molecular Biology and Pathophysiological Implications","volume":"9","author":"Cairo","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2021.719187","article-title":"Transcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: Mechanisms, Biology and Role in Disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol 2021 224"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3892\/MMR.2020.11376","article-title":"Erastin Induces Apoptotic and Ferroptotic Cell Death by Inducing ROS Accumulation by Causing Mitochondrial Dysfunction in Gastric Cancer Cell HGC\u221227","volume":"22","author":"Sun","year":"2020","journal-title":"Mol Med Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12936","article-title":"Ferroptosis Inducer Erastin Sensitizes NSCLC Cells to Celastrol Through Activation of the ROS-Mitochondrial Fission-Mitophagy Axis","volume":"15","author":"Liu","year":"2021","journal-title":"Mol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.868351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:10:01Z","timestamp":1648725001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.868351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":59,"alternative-id":["10.3389\/fonc.2022.868351"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.868351","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"868351"}}